Vivos Therapeutics Sortino Ratio
| VVOS Stock | | | USD 0.66 -0.06 -8.33% |
The Sortino Ratio measures risk-adjusted return using only downside deviation rather than total volatility. Unlike the Sharpe Ratio, which penalizes both upside and downside volatility equally, the Sortino Ratio penalizes only returns below a target threshold, making it a more targeted measure of harmful volatility. Below is Vivos Therapeutics's current Sortino Ratio with peer comparisons and related risk metrics.
Current Sortino Ratio Value
Vivos Therapeutics carries a Sortino Ratio of 0, consistent with its current reading on this measure. This reflects Vivos Therapeutics's positioning relative to its own recent range within Stock.
Sortino Ratio | = | ER[a] - ER[b]DD |
| = | 0 | |
| ER[a] | = | Expected return on investing in Vivos Therapeutics |
| ER[b] | = | Expected return on market index or selected benchmark |
| DD | = | Downside Deviation |
Sortino Ratio Peers Comparison
Sortino Ratio Relative To Other Indicators
The chart below plots Sortino Ratio against Maximum Drawdown for Vivos Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Sortino Ratio while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Compare Vivos Therapeutics to PeersMethodology, Assumptions & Data Sources
The current Sortino Ratio for Vivos Therapeutics is 0. The Sortino Ratio for Vivos Therapeutics applies a standardized calculation to daily closing prices and, where applicable, volume data across the selected period. Data sources include daily closing prices from supported exchanges, with standard corporate action adjustments applied. Values are specific to the selected time horizon and may differ across measurement periods. This indicator does not constitute investment advice.
Other Technical Indicators